Evidence map›Paper›PMID 31673011›Full record

ArticleScientific reports2019

IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery status.

Andra Ceausu, Esther Rodríguez-Gallego, Joaquim Peraire, Miguel López-Dupla, Pere Domingo, Consuelo Viladés, Judit Vidal-Gonzalez, Maria Peraire, Carles Perpiñán, Yolanda María Pacheco and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Molecular Diagnostics ofDiseases (Basel, Switzerland) · 2024
    Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 1 country.

Andra CeausuHospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.
Esther Rodríguez-GallegoHospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.
Joaquim PeraireHospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.
Miguel López-DuplaHospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.
Pere DomingoInfectious Diseases Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Consuelo ViladésHospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.
Judit Vidal-GonzalezUniversitat de Barcelona, Barcelona, Spain.
Maria PeraireUniversitat Rovira i Virgili, Tarragona, Spain.
Carles PerpiñánUniversitat Rovira i Virgili, Tarragona, Spain.
Yolanda María PachecoLaboratory of Immunology, Institute of Biomedicine of Seville, IBiS, UGC Clinical Laboratories, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
Sergi VelosoHospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.
Verónica AlbaHospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.
Montserrat VargasHospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.
Alfonso J CastellanoHospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.
Ezequiel Ruiz-MateosClinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
Josep MallolasHIV Unit. Infectious Diseases Service, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain.
Francesc VidalHospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain. fvidalmarsal.hj23.ics@gencat.cat.
Anna RullHospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.
Universidad Rovira i Virgili · ESInstitut d'Investigació Sanitària Pere Virgili · ESHospital Universitari Joan XXIII de Tarragona · ESInstituto de Biomedicina de Sevilla · ESUniversitat de Barcelona · ESHospital de Sant Pau · ESHospital Universitario Son Espases · ES

Funding

Radiosensitization with Recombinant Antibodies to EGFrR01CA089297 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BONNER, JAMES A · 2002 to 2005
$954k
NIEHS NIH HHS 27300C0032
6 · The paper itself

Abstract

A relationship between polymorphisms in genes encoding interleukin 7 (IL-7) and its cellular receptor (IL-7R) and antiretroviral therapy (ART)-associated immune recovery in HIV subjects has been previously reported. However, details of this relationship remain unclear, and the association of these polymorphisms with circulating IL-7/IL-7R levels is scarce. Here, we explored whether IL-7/IL-7R axis was associated with quantitative CD4

Indexed as

AdultAnti-HIV AgentsCD4 Lymphocyte CountCohort StudiesFemaleHIV InfectionsHomeostasisHumansInterleukin-7MaleMiddle AgedReceptors, Interleukin-7Anti-HIV AgentsIL7 protein, humanInterleukin-7Receptors, Interleukin-7

Identifiers

PMID31673011
PMCPMC6823538
OpenAlexW2982645096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.